Metastatic breast cancer
Showing 9 of 0 results
- Tolerability of first-line treatment with ribociclib for metastatic breast cancer using two large US data sources
San Antonio Breast Cancer Symposium
- Comparative overall survival of CDK4/6is plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting
San Antonio Breast Cancer Symposium
- Testing patterns and prevalence of PIK3CA, AKT1, and PTEN alterations among patients with HR+/HER2- metastatic breast cancer in the US
Poster presented at: ASCO 2024; May 31-June 4, 2024; Chicago, IL
- Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer
Breast Cancer Research and Treatment
- Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
Contemporary Clinical Trials Communications